Plasminogen activator inhibitor type 1 gene polymorphisms and haplotypes are associated with plasma plasminogen activator inhibitor type 1 levels but not with myocardial infarction or stroke

American Heart Journal

Volumn 152, Issue 6, 2006, Pages 1109-1115

  Ding, Jingzhong ^a   Nicklas, Barbara J ^a   Fallin, Margaret D ^b   de Rekeneire, Nathalie ^c   Kritchevsky, Stephen B ^a   Pahor, Marco ^a   Rodondi, Nicolas ^d   Li, Rongling ^e   Zmuda, Joseph M ^f   Harris, Tamara B ^c  

^a WAKE FOREST BAPTIST HEALTH   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c NATIONAL INSTITUTE ON AGING   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^f UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1;

AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HAPLOTYPE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NEGRO; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; STATISTICAL MODEL; STROKE;

AGED; ALLELES; CEREBROVASCULAR ACCIDENT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINEAR MODELS; MALE; MYOCARDIAL INFARCTION; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES;

EID: 33845304321     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2006.06.021     Document Type: Article

References (26)

1. Kohler H.P., and Grant P.J. Plasminogen-activator inhibitor type 1 and coronary artery disease. N Engl J Med 342 (2000) 1792-1801
2. Eriksson P., Kallin B., and 't Hooft F.M. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci U S A 92 (1995) 1851-1855
3. Margaglione M., Cappucci G., Colaizzo D., et al. The PAI-1 gene locus 4G/5G polymorphism is associated with a family history of coronary artery disease. Arterioscler Thromb Vasc Biol 18 (1998) 152-156
4. Ossei-Gerning N., Mansfield M.W., Stickland M.H., et al. Plasminogen activator inhibitor-1 promoter 4G/5G genotype and plasma levels in relation to a history of myocardial infarction in patients characterized by coronary angiography. Arterioscler Thromb Vasc Biol 17 (1997) 33-37
5. Ye S., Green F.R., Scarabin P.Y., et al. The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Etude CasTemoins de I'nfarctus du Mycocarde. Thromb Haemost 74 (1995) 837-841
6. Festa A., D'Agostino Jr. R., Rich S.S., et al. Promoter (4G/5G) plasminogen activator inhibitor-1 genotype and plasminogen activator inhibitor-1 levels in blacks, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Circulation 107 (2003) 2422-2427
7. Yamada Y., Izawa H., Ichihara S., et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 347 (2002) 1916-1923
8. Fu L., Jin H., Song K., et al. Relationship between gene polymorphism of the PAI-1 promoter and myocardial infarction. Chin Med J (Engl) 114 (2001) 266-269
9. Aucella F., Margaglione M., Vigilante M., et al. PAI-1 4G/5G and ACE I/D gene polymorphisms and the occurrence of myocardial infarction in patients on intermittent dialysis. Nephrol Dial Transplant 18 (2003) 1142-1146
10. Doggen C.J., Bertina R.M., Cats V.M., et al. The 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with myocardial infarction. Thromb Haemost 82 (1999) 115-120
11. Ridker P.M., Hennekens C.H., Lindpaintner K., et al. Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men. Circulation 95 (1997) 59-62
12. Boekholdt S.M., Bijsterveld N.R., Moons A.H., et al. Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: a systematic review. Circulation 104 (2001) 3063-3068
13. Hindorff L.A., Schwartz S.M., Siscovick D.S., et al. The association of PAI-1 promoter 4G/5G insertion/deletion polymorphism with myocardial infarction and stroke in young women. J Cardiovasc Risk 9 (2002) 131-137
14. Hoekstra T., Geleijnse J.M., Kluft C., et al. 4G/4G genotype of PAI-1 gene is associated with reduced risk of stroke in elderly. Stroke 34 (2003) 2822-2828
15. Bang C.O., Park H.K., Ahn M.Y., et al. 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and insertion/deletion polymorphism of the tissue-type plasminogen activator gene in atherothrombotic stroke. Cerebrovasc Dis 11 (2001) 294-299
16. Catto A.J., Carter A.M., Stickland M., et al. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphism and levels in subjects with cerebrovascular disease. Thromb Haemost 77 (1997) 730-734
17. Elbaz A., Cambien F., and Amarenco P. Plasminogen activator inhibitor genotype and brain infarction. Circulation 103 (2001) e13-e14
18. Endler G., Lalouschek W., Exner M., et al. The 4G/4G genotype at nucleotide position -675 in the promoter region of the plasminogen activator inhibitor 1 (PAI-1) gene is less frequent in young patients with minor stroke than in controls. Br J Haematol 110 (2000) 469-471
19. Heijmans B.T., Westendorp R.G., Knook D.L., et al. Angiotensin I-converting enzyme and plasminogen activator inhibitor-1 gene variants: risk of mortality and fatal cardiovascular disease in an elderly population-based cohort. J Am Coll Cardiol 34 (1999) 1176-1183
20. Roest M., van der Schouw Y.T., Banga J.D., et al. Plasminogen activator inhibitor 4G polymorphism is associated with decreased risk of cerebrovascular mortality in older women. Circulation 101 (2000) 67-70
21. Zhang K., Calabrese P., Nordborg M., et al. Haplotype block structure and its applications to association studies: power and study designs. Am J Hum Genet 71 (2002) 1386-1394
22. Loskutoff D.J., Linders M., Keijer J., et al. Structure of the human plasminogen activator inhibitor 1 gene: nonrandom distribution of introns. Biochemistry 26 (1987) 3763-3768
23. Stephens M., Smith N.J., and Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68 (2001) 978-989
24. Kumar S., Tamura K., Jakobsen I.B., et al. MEGA2: molecular evolutionary genetics analysis software. Bioinformatics 17 (2001) 1244-1245
25. Wilcox T.P., Zwickl D.J., Heath T.A., et al. Phylogenetic relationships of the dwarf boas and a comparison of Bayesian and bootstrap measures of phylogenetic support. Mol Phylogenet Evol 25 (2002) 361-371
26. Iacoviello L., Burzotta F., Di Castelnuovo A., et al. The 4G/5G polymorphism of PAI-1 promoter gene and the risk of myocardial infarction: a meta-analysis. Thromb Haemost 80 (1998) 1029-1030